DAVERLA Trademark

Trademark Overview

On Monday, June 24, 2019, a trademark application was filed for DAVERLA with the United States Patent and Trademark Office. The USPTO has given the DAVERLA trademark a serial number of 88487100. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 18, 2022. This trademark is owned by Sunovion Pharmaceuticals Inc.. The DAVERLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceutical preparations for treating attention-deficit/hyperactivity disorder (ADHD); pharmaceutical preparations for treating eating disorders
daverla

General Information

Serial Number88487100
Word MarkDAVERLA
Filing DateMonday, June 24, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 18, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 22, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceutical preparations for treating attention-deficit/hyperactivity disorder (ADHD); pharmaceutical preparations for treating eating disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 3, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSunovion Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMarlborough, MA 01752
Party NameSunovion Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMarlborough, MA 01752

Trademark Events

Event DateEvent Description
Monday, July 18, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 18, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, December 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 15, 2021SOU EXTENSION 4 GRANTED
Wednesday, December 15, 2021SOU EXTENSION 4 FILED
Wednesday, December 15, 2021TEAS EXTENSION RECEIVED
Friday, June 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 16, 2021SOU EXTENSION 3 GRANTED
Wednesday, June 16, 2021SOU EXTENSION 3 FILED
Wednesday, June 16, 2021TEAS EXTENSION RECEIVED
Thursday, January 7, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, January 7, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 7, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, January 7, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 7, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 7, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, December 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 17, 2020SOU EXTENSION 2 GRANTED
Thursday, December 17, 2020SOU EXTENSION 2 FILED
Thursday, December 17, 2020TEAS EXTENSION RECEIVED
Friday, June 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 17, 2020SOU EXTENSION 1 GRANTED
Wednesday, June 17, 2020SOU EXTENSION 1 FILED
Wednesday, June 17, 2020TEAS EXTENSION RECEIVED
Tuesday, December 17, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 22, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 22, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 2, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 17, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 13, 2019ASSIGNED TO EXAMINER
Wednesday, July 3, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 27, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

daverla pharmaceutical treating preparations disorders hyperactivity adhd eating deficit disorder diseases